XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jul. 01, 2018
Jul. 02, 2017
Jul. 01, 2018
Jul. 02, 2017
Revenues $ 22,864 $ 19,939 $ 45,933 $ 41,974
Cost of products sold 16,314 13,718 32,101 28,863
Gross profit 6,550 6,221 13,832 13,111
Operating expenses:        
Research and development 1,218 1,185 2,318 2,323
Selling, general and administrative 3,700 3,714 7,526 7,625
Total operating expenses 4,918 4,899 9,844 9,948
Operating income 1,632 1,322 3,988 3,163
Interest and financing expense 21 41 54 109
Miscellaneous (107) 8 (6) 33
Income before income tax provision 1,718 1,273 3,940 3,021
Income tax provision 78 179 133 266
Net income 1,640 1,094 3,807 2,755
Net income attributable to non-controlling interest 13 30 6
Net income attributable to Ultralife Corporation 1,627 1,094 3,777 2,749
Other comprehensive (loss) income:        
Foreign currency translation adjustments (1,177) 494 (425) 753
Comprehensive income attributable to Ultralife Corporation $ 450 $ 1,588 $ 3,352 $ 3,502
Net income per share attributable to Ultralife common shareholders – basic (in dollars per share) $ 0.10 $ 0.07 $ 0.24 $ 0.18
Net income per share attributable to Ultralife common shareholders – diluted (in dollars per share) $ 0.10 $ 0.07 $ 0.23 $ 0.17
Weighted average shares outstanding – basic (in shares) 15,922 15,510 15,813 15,461
Potential common shares (in shares) 598 340 541 291
Weighted average shares outstanding - diluted (in shares) 16,520 15,850 16,354 15,752